Drug Criteria & Outcomes: Pharmacia initiates U.S. recall of Deltasone tablets
July 1, 2001 1 minute read
Drug Criteria & Outcomes
Pharmacia initiates U.S. recall of Deltasone tablets
In cooperation with the Food and Drug Administration, Pharmacia Corp. is conducting a recall in the United States of its 500-count bottles of Deltasone tablets (prednisone tablets, USP), 10 mg, lot no. 29DRB. No other lots or countries are affected by this recall.
The recall is based on one report from a pharmacist that a bottle labeled as Deltasone tablets, 10 mg, actually contained Deltasone tablets, 5 mg. Although this may have been the only mislabeled bottle, other mislabeled bottles may have been distributed. To date, the company has received no reports of patients actually receiving an incorrect dose of Deltasone as a result of this situation.
The effect on patients receiving half the prescribed dose of Deltasone tablets depends on the condition being treated. The effect could be life-threatening and could result in hospitalization or death. Patients who have taken or suspect they may have taken an incorrect dose of Deltasone are advised to contact their health care provider immediately.
Pharmacia is notifying pharmacies nationwide of this recall. Pharmacists are being asked to contact any patients who have received a prescription for Deltasone tablets, 10 mg since Dec. 12, 2000, and to instruct them to return any remaining tablets to the pharmacy for examination. Patients who may have received their prescription by mail order should call their mail order provider, visit their physician or local pharmacy, or call the Pharmacia Patient Information Hotline at (888) 691-6813 for assistance.
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content